CC
EDIT icon

Centiva Capital’s Editas Medicine EDIT Stock Holding History

Centiva Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,992
Closed -$44.3K – 1867
2024
Q3 		$44.3K Buy
12,992
+2,970
+30% +$12.9K ﹤0.01% 2005
2024
Q2 		$46.8K Buy
+10,022
New +$56.5K ﹤0.01% 1930
2021
Q3 		– Sell
-12,713
Closed -$720K – 1366
2021
Q2 		$720K Buy
+12,713
New +$470K 0.02% 699

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centiva Capital's EDIT Position: Q4 2024 in Review

Centiva Capital sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 12,992 shares — an estimated $44.3K sold.

Centiva Capital first reported a position in EDIT in Q2 2021 and held it in 3 quarters. The position peaked at $720K in Q2 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Centiva Capital reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 12,992 Editas Medicine shares in Q4 2024, an estimated $44.3K.
  • Centiva Capital first reported a position in Editas Medicine in Q2 2021 and held it in 3 quarters.
  • Centiva Capital's Editas Medicine position peaked at $720K in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.